News

The publication’s team in the front cover of Theranostics journal

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.

Vikova V. et al. pp.540

Diag2Tec s’attaque au myélome multiple

http://www.occitanie-invest.com/diag2tec-sattaque-myelome-multiple/

Diag2Tec présente son pitch aux investisseurs lors du salon Occitanie Invest

Dossier de presse Occitanie Invest / Salon de l’Entreprise

ADDRESS

Diag2Tec
Cap Omega, Rond-Point Benjamin Franklin
CS 39521
34960 Montpellier, France
Email: contact@diag2tec.com